As of April 18, 2025, Trevena (TRVN) has a market cap of $967,442 Dollars USD. According to our data, Trevena is ranked No.9245 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $967,442 Dollars |
-25.33%
|
Dec 31, 2024 | $1.30 M |
-91.69%
|
Dec 29, 2023 | $15.59 M |
-49.51%
|
Dec 30, 2022 | $30.88 M |
-90.19%
|
Dec 31, 2021 | $0.31 B |
-72.76%
|
Dec 31, 2020 | $1.16 B |
154.46%
|
Dec 31, 2019 | $0.45 B |
95.58%
|
Dec 31, 2018 | $0.23 B |
-73.13%
|
Dec 29, 2017 | $0.86 B |
-72.79%
|
Dec 30, 2016 | $3.17 B |
-44.00%
|
Dec 31, 2015 | $5.67 B |
75.59%
|
Dec 31, 2014 | $3.23 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Cara Therapeutics
CARA
|
$24.33 M |
0.000 M
|
![]() USA
|
![]() Pacira Biosciences
PCRX
|
$1.14 B |
0.000 M
|
![]() USA
|
![]() Heron Therapeutics
HRTX
|
$0.28 B |
-0.000 M
|
![]() USA
|
![]() Collegium Pharmaceutical
COLL
|
$0.87 B |
0.000 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
![]() Israel
|
![]() Assertio Therapeutics
ASRT
|
$58.46 M |
0.038 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.45 B |
-0.000 M
|
![]() Ireland
|
Market Cap | = | TRVN Stock Price | * | TRVN Shares Outstanding |
= | $1.12 | * | 0.86 M | |
= | $967,442 Dollars |